0001209191-13-048153.txt : 20131011 0001209191-13-048153.hdr.sgml : 20131011 20131011141801 ACCESSION NUMBER: 0001209191-13-048153 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131011 FILED AS OF DATE: 20131011 DATE AS OF CHANGE: 20131011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3876 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 3876 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC CENTRAL INDEX KEY: 0001280238 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55021 FILM NUMBER: 131147713 BUSINESS ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 4050 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 4153624022 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 4050 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG CENTRAL INDEX KEY: 0001280265 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55021 FILM NUMBER: 131147714 BUSINESS ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 4153624022 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 FORMER NAME: FORMER CONFORMED NAME: ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG DATE OF NAME CHANGE: 20040213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALTA BIOPHARMA PARTNERS III LP CENTRAL INDEX KEY: 0001257444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55021 FILM NUMBER: 131147715 BUSINESS ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 4153624022 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER, SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2013-10-11 0 0001042074 CymaBay Therapeutics, Inc. NONE 0001257444 ALTA BIOPHARMA PARTNERS III LP ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001280265 ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001280238 ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 Common Stock 64501 I Alta BioPharma Partners III GmbH & Co. Beteiligungs KG Common Stock 960433 D Common Stock 23668 I Alta Embarcadero BioPharma Partners III, LLC Warrants (right to buy) 5.75 2013-09-30 2018-09-30 Common Stock 4613 I Alta BioPharma Partners III GmbH & Co. Beteiligungs KG Warrants (right to buy) 5.75 2013-09-30 2018-09-30 Common Stock 68693 D Warrants (right to buy) 5.75 2013-09-30 2018-09-30 Common Stock 1692 I Alta Embarcadero BioPharma Partners III, LLC The securities are held by Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABP III KG"). Alta BioPharma Management Partners III, LLC ("ABMP") is the managing imited partner of ABP III KG. ABMP disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. The securities are held by Alta BioPharma Partners III, L.P. ("ABP III"). ABMP is the general partner of ABP III. ABMP disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. The securities are held by Alta Embarcadero BioPharma Partners III, LLC ("AEBP III"). ABMP is the manager of AEBP III. ABMP disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. /s/ Edward E. Penhoet 2013-10-11